Semaglutide is gaining traction as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and reducing glucagon https://iwanhmyb028359.slypage.com/36316512/grasping-semaglutide-a-comprehensive-guide